1. Prawjaeng, J, Leelahavarong, P, Budtarad, N, Pilasant, S, Chanjam, C, Katchamart, W et al.. Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity. BMC Health Serv Res. 2023;23 (1):561. doi: 10.1186/s12913-023-09595-1. PubMed PMID:37259090 PubMed Central PMC10230705.
  2. Pichaiwong, W, Lawanaskol, S, Phinyo, P, Kitumnuaypong, T. The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis. Lupus. 2023;32 (3):444-452. doi: 10.1177/09612033221149874. PubMed PMID:36602394 .
  3. Sumethkul, K, Urailert, I, Kitumnuaypong, T, Angthararak, S, Silpa-Archa, S. The incidence, risk factor, and time to develop rheumatologic diseases after isolated inflammatory eye diseases: a 12-year cohort study. Clin Rheumatol. 2022;41 (4):1003-1012. doi: 10.1007/s10067-021-06005-x. PubMed PMID:35001319 .
  4. Sumethkul, K, Kitumnuaypong, T, Angthararak, S, Pichaiwong, W. Low-dose cyclosporine for active lupus nephritis: a dose titration approach. Clin Rheumatol. 2019;38 (8):2151-2159. doi: 10.1007/s10067-019-04469-6. PubMed PMID:30937637 .
  5. Chiowchanwisawakit, P, Katchamart, W, Osiri, M, Narongroeknawin, P, Chevaisrakul, P, Kitumnuaypong, T et al.. Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. J Clin Rheumatol. 2019;25 (1):9-15. doi: 10.1097/RHU.0000000000000741. PubMed PMID:29517554 .
  6. Mease, PJ, Jeka, S, Jaller, JJ, Kitumnuaypong, T, Louthrenoo, W, Mann, H et al.. CNTO6785, a Fully Human Antiinterleukin 17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: A Randomized, Placebo-controlled, Phase II, Dose-ranging Study. J Rheumatol. 2018;45 (1):22-31. doi: 10.3899/jrheum.161238. PubMed PMID:29093159 .
  7. Narongroeknawin, P, Chevaisrakul, P, Kasitanon, N, Kitumnuaypong, T, Mahakkanukrauh, A, Siripaitoon, B et al.. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. Int J Rheum Dis. 2018;21 (1):170-178. doi: 10.1111/1756-185X.12937. PubMed PMID:28737837 .
  8. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  9. Songpatanasilp, T, Sritara, C, Kittisomprayoonkul, W, Chaiumnuay, S, Nimitphong, H, Charatcharoenwitthaya, N et al.. Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis. Osteoporos Sarcopenia. 2016;2 (4):191-207. doi: 10.1016/j.afos.2016.10.002. PubMed PMID:30775487 PubMed Central PMC6372784.
  10. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  11. Lee, EB, Fleischmann, R, Hall, S, Wilkinson, B, Bradley, JD, Gruben, D et al.. Tofacitinib versus methotrexate in rheumatoid arthritis. N Engl J Med. 2014;370 (25):2377-86. doi: 10.1056/NEJMoa1310476. PubMed PMID:24941177 .
  12. Sumethkul, K, Boonyaratavej, S, Kitumnuaypong, T, Angthararuk, S, Cheewasat, P, Manadee, N et al.. The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int. 2013;33 (6):1461-7. doi: 10.1007/s00296-012-2537-7. PubMed PMID:23179257 .
  13. Flagg, SD, Meador, R, Hsia, E, Kitumnuaypong, T, Schumacher, HR Jr. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthritis Rheum. 2005;53 (4):613-7. doi: 10.1002/art.21323. PubMed PMID:16082643 .
  14. Kitumnuaypong, T, Scalzi, LV, Nalbant, S, Von Feldt, JM, Schumacher, HR Jr. Is there a role for Chlamydia pneumoniae infection in systemic lupus erythematosus and in the associated atherosclerotic cardiovascular disease?. Clin Exp Rheumatol. 2004;22 (3):339-42. . PubMed PMID:15144130 .
  15. Nalbant, S, Corominas, H, Hsu, B, Chen, LX, Schumacher, HR, Kitumnuaypong, T et al.. Ultrasonography for assessment of subcutaneous nodules. J Rheumatol. 2003;30 (6):1191-5. . PubMed PMID:12784388 .
  16. Nalbant, S, Martinez, JA, Kitumnuaypong, T, Clayburne, G, Sieck, M, Schumacher, HR Jr et al.. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage. 2003;11 (1):50-4. doi: 10.1053/joca.2002.0861. PubMed PMID:12505487 .
  17. Meador, R, Hsia, E, Kitumnuaypong, T, Schumacher, HR. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol. 2002;20 (6 Suppl 28):S130-4. . PubMed PMID:12463463 .
Search PubMed